172 related articles for article (PubMed ID: 20967345)
1. Investigation of the influence of high-risk human papillomavirus on the biochemical composition of cervical cancer cells using vibrational spectroscopy.
Ostrowska KM; Malkin A; Meade A; O'Leary J; Martin C; Spillane C; Byrne HJ; Lyng FM
Analyst; 2010 Dec; 135(12):3087-93. PubMed ID: 20967345
[TBL] [Abstract][Full Text] [Related]
2. Correlation of p16(INK4A) expression and HPV copy number with cellular FTIR spectroscopic signatures of cervical cancer cells.
Ostrowska KM; Garcia A; Meade AD; Malkin A; Okewumi I; O'Leary JJ; Martin C; Byrne HJ; Lyng FM
Analyst; 2011 Apr; 136(7):1365-73. PubMed ID: 21290054
[TBL] [Abstract][Full Text] [Related]
3. Sensitivity to Fas-mediated apoptosis in high-risk HPV-positive human cervical cancer cells: relationship with Fas, caspase-8, and Bid.
Hougardy BM; van der Zee AG; van den Heuvel FA; Timmer T; de Vries EG; de Jong S
Gynecol Oncol; 2005 May; 97(2):353-64. PubMed ID: 15863130
[TBL] [Abstract][Full Text] [Related]
4. A spectral phenotype of oncogenic human papillomavirus-infected exfoliative cervical cytology distinguishes women based on age.
Kelly JG; Cheung KT; Martin C; O'Leary JJ; Prendiville W; Martin-Hirsch PL; Martin FL
Clin Chim Acta; 2010 Aug; 411(15-16):1027-33. PubMed ID: 20359472
[TBL] [Abstract][Full Text] [Related]
5. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
[TBL] [Abstract][Full Text] [Related]
6. Recombinant adenovirus-p53 gene transfer and cell-specific growth suppression of human cervical cancer cells in vitro and in vivo.
Ahn WS; Bae SM; Lee KH; Lee JM; Namkoong SE; Chun HJ; Kim CK; Kim YW
Gynecol Oncol; 2004 Feb; 92(2):611-21. PubMed ID: 14766255
[TBL] [Abstract][Full Text] [Related]
7. Generation of type-specific probes for the detection of single-copy human papillomavirus by a novel in situ hybridization method.
Huang CC; Qiu JT; Kashima ML; Kurman RJ; Wu TC
Mod Pathol; 1998 Oct; 11(10):971-7. PubMed ID: 9796725
[TBL] [Abstract][Full Text] [Related]
8. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer.
Wallin KL; Wiklund F; Angström T; Bergman F; Stendahl U; Wadell G; Hallmans G; Dillner J
N Engl J Med; 1999 Nov; 341(22):1633-8. PubMed ID: 10572150
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for cervical neoplasia in Denmark.
Kjaer SK
APMIS Suppl; 1998; 80():1-41. PubMed ID: 9693662
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus testing for primary cervical cancer screening.
Grce M; Davies P
Expert Rev Mol Diagn; 2008 Sep; 8(5):599-605. PubMed ID: 18785808
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of RAS association domain family 1A gene in cervical carcinomas and the role of human papillomavirus infection.
Kuzmin I; Liu L; Dammann R; Geil L; Stanbridge EJ; Wilczynski SP; Lerman MI; Pfeifer GP
Cancer Res; 2003 Apr; 63(8):1888-93. PubMed ID: 12702579
[TBL] [Abstract][Full Text] [Related]
12. HPV+ cervical carcinomas and cell lines display altered expression of caspases.
Aréchaga-Ocampo E; Pereira-Suárez AL; del Moral-Hernández O; Cedillo-Barrón L; Rodríguez-Sastre MA; Castillo-Alvarez A; López-Bayghen E; Villegas-Sepúlveda N
Gynecol Oncol; 2008 Jan; 108(1):10-8. PubMed ID: 17936882
[TBL] [Abstract][Full Text] [Related]
13. [Detection of physical status of human papillomavirus 16 in cervical cancer tissue and SiHa cell line by multiplex real-time polymerase chain reaction].
Zheng Y; Peng ZL; Lou JY; Wang H
Ai Zheng; 2006 Mar; 25(3):373-7. PubMed ID: 16536998
[TBL] [Abstract][Full Text] [Related]
14. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention.
Castellsagué X; Díaz M; de Sanjosé S; Muñoz N; Herrero R; Franceschi S; Peeling RW; Ashley R; Smith JS; Snijders PJ; Meijer CJ; Bosch FX;
J Natl Cancer Inst; 2006 Mar; 98(5):303-15. PubMed ID: 16507827
[TBL] [Abstract][Full Text] [Related]
15. In vitro antigene therapy targeting HPV-16 E6 and E7 in cervical carcinoma.
Madrigal M; Janicek MF; Sevin BU; Perras J; Estape R; Peñalver M; Averette HE
Gynecol Oncol; 1997 Jan; 64(1):18-25. PubMed ID: 8995542
[TBL] [Abstract][Full Text] [Related]
16. Early detection of cervical neoplasia by Raman spectroscopy.
Jess PR; Smith DD; Mazilu M; Dholakia K; Riches AC; Herrington CS
Int J Cancer; 2007 Dec; 121(12):2723-8. PubMed ID: 17724716
[TBL] [Abstract][Full Text] [Related]
17. Adenoviral p53 effects and cell-specific E7 protein-protein interactions of human cervical cancer cells.
Choi JW; Ahn WS; Bae SM; Lee DB; Kim YW
Biosens Bioelectron; 2005 May; 20(11):2236-43. PubMed ID: 15797321
[TBL] [Abstract][Full Text] [Related]
18. Physical status of multiple human papillomavirus genotypes in flow-sorted cervical cancer cells.
Vermeulen CF; Jordanova ES; Szuhai K; Kolkman-Uljee S; Vrede MA; Peters AA; Schuuring E; Fleuren GJ
Cancer Genet Cytogenet; 2007 Jun; 175(2):132-7. PubMed ID: 17556069
[TBL] [Abstract][Full Text] [Related]
19. Integrating human papillomavirus vaccination in cervical cancer control programmes.
Franco EL; Coutlée F; Ferenczy A
Public Health Genomics; 2009; 12(5-6):352-61. PubMed ID: 19684447
[TBL] [Abstract][Full Text] [Related]
20. [Can human papillomavirus testing and vaccination prevent cervical cancer?].
Lie AK; Bjørge T; Helland A; Hagen B; Skjeldestad FE; Hagmar B; Thoresen S
Tidsskr Nor Laegeforen; 2001 Oct; 121(25):2947-51. PubMed ID: 11715778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
